Skip to main
FPRX
FPRX logo

FPRX Earnings Dates & Reports

FPRX Most Recent Earnings

Report DateMar 22, 2021
Period EndingQ4 2020
Est. EPS-$0.52
Actual EPS-$0.50
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FPRX Earnings per Share (EPS) History

Signup for full access
Browse free

FPRX Latest Earnings

The value each FPRX share was expected to gain vs. the value each share gained.

FPRX reported its most recent earnings on Mar 22, 2021 for Q4 2020, posting earnings per share (EPS) of -$0.50. This exceeded analysts' expectations of -$0.52 by 3.85%, marking a Beat.

For comparison, Five Prime Therapeutics reported EPS of -$0.89 in the same quarter last year.

The company is expected to announce its next earnings report on 03/22/2021, with analysts projecting an EPS of $0.

FPRX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2020Mar 22, 2021
-$0.52-$0.50-3.85%
DeckReportListen
Q3 2020Nov 3, 2020
-$0.60-$0.74+23.33%
Q2 2020Aug 6, 2020
-$0.69-$0.48-30.43%
Q1 2020May 7, 2020
-$0.67-$0.57-14.93%
Q4 2019Feb 27, 2020
-$0.97-$0.89-8.25%

FPRX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Five Prime Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 3, 2020
Aug 6, 2020
May 7, 2020
Feb 27, 2020

FPRX Earnings FAQs

FPRX last reported earnings on Mar 22, 2021 for Q4 2020, posting an EPS of -$0.50, which Beat the estimate of -$0.52 by 3.85%.

For Q4 2020, FPRX reported an EPS of -$0.50, exceeding analysts' estimate of -$0.52 by 3.85%.

For Q4 2020, FPRX Beat expectations with an actual EPS of -$0.50 vs. an estimated EPS of -$0.52.

Following the last earnings report on Mar 22, 2021, FPRX's stock price moved — from — to —.

The next FPRX earnings call is scheduled for Mar. 22, 2021, where executives will discuss financial results and outlook.

Five Prime Therapeutics (FPRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.